Nurtec Odt Tablet, Orally Disintegrating
Product Images NDC 72618-3001

16 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Nurtec Odt (NDC 72618-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F0741274 9808 5644 E053 2995a90a021e

F0741274 9808 5644 E053 2995a90a021e
Close-up image of a white, round tablet identified as NURTEC ODT, an orally disintegrating tablet containing rimegepant sulfate. The tablet shows two distinct shallow score marks on its surface. No additional text or markings are visible on this tablet image.*
FDA Label Image

Image (Nurtec 01)

Image (Nurtec 01)
NURTEC ODT 75 mg orally disintegrating tablet packaging label. The product contains the active ingredient rimegepant sulfate in a 75 mg strength. The label displays the Pfizer Laboratories division of Pfizer Inc as the labeler. The image shows the front of the tablet carton with dosage form and strength clearly marked.*
FDA Label Image

Chemical Structure (Nurtec 02)

Chemical Structure (Nurtec 02)
Chemical structure diagram of the active ingredient rimegepant sulfate, showing its molecular composition including sulfate and hydrate components, corresponding to the 75 mg strength of NURTEC ODT orally disintegrating tablets.*
FDA Label Image

Figure 1 (Nurtec 03)

Figure 1 (Nurtec 03)
A line graph depicting the percent of subjects achieving pain freedom over time, comparing NURTEC ODT 75 mg tablets and placebo. The x-axis represents time in hours from dose (0 to 2 hours), and the y-axis shows the percent achieving pain freedom (0% to 100%). NURTEC ODT 75 mg shows a higher percentage than placebo at each time point after dosing.*
FDA Label Image

Figure 2 (Nurtec 04)

Figure 2 (Nurtec 04)
A line graph comparing the percentage of subjects achieving MBS freedom over time between NURTEC ODT 75 mg and placebo. The x-axis shows time in hours from dose (0 to 2 hours), and the y-axis shows percent achieving MBS freedom (0% to 100%). Two lines represent NURTEC ODT 75 mg and placebo, with NURTEC ODT showing higher percentages throughout the time points.*
FDA Label Image

Figure 3 (Nurtec 05)

Figure 3 (Nurtec 05)
A line graph comparing the change from baseline in monthly migraine days over three months between placebo and rimegepant 75 mg. The Y-axis represents change from baseline in monthly migraine days, and the X-axis represents time points: baseline, month 1, month 2, and month 3. Data points with error bars are shown for both treatment groups, with rimegepant 75 mg demonstrating a greater reduction over time than placebo.*
FDA Label Image

Figure 4 (Nurtec 06)

Figure 4 (Nurtec 06)
A bar chart comparing the percentage of patients with reductions in migraine days per month between placebo and rimegepant 75 mg groups. The horizontal axis shows ranges of migraine day reductions, and the vertical axis shows the percent of patients. Data indicates higher patient percentages with migraine reductions in the rimegepant group compared to placebo across most categories.*
FDA Label Image

Image (Nurtec 07)

Image (Nurtec 07)
NURTEC ODT 75 mg orally disintegrating tablets packaging label. The front of the blister card shows ten tablets arranged in two rows of five, with alternating blue and white coloring. The label includes the generic name rimegepant sulfate, strength 75 mg, and manufacturer Pfizer Laboratories Div Pfizer Inc. The packaging is designed for prescription use.*
FDA Label Image

Logo (Nurtec 07a)

FDA Label Image

Logo (Nurtec 07b)

FDA Label Image

Principal Display Panel (75 mg Tablet Blister Pack Carton)

Principal Display Panel (75 mg Tablet Blister Pack Carton)
Packaging label for NURTEC ODT, containing 75 mg rimegepant sulfate orally disintegrating tablets. The label shows the brand and generic names, dosage strength, and instructions for storage and usage. Manufactured by Pfizer Laboratories Div Pfizer Inc, the carton indicates a blister pack containing orally disintegrating tablets with instructions not to push the tablet through the foil backing.*
FDA Label Image

Principal Display Panel (75 mg NURTEC ODT Blister Pack)

Principal Display Panel (75 mg NURTEC ODT Blister Pack)
NURTEC ODT 75 mg orally disintegrating tablets packaging label showing the labeler Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, usage directions, dosage information, and manufacturer details from Biohaven Pharmaceuticals, Inc. The package contains 8 tablets of rimegepant sulfate in orally disintegrating tablet form. The label features a multicolor design with purple and teal accents and a barcode.*
FDA Label Image

Principal Display Panel (75 mg Tablet Blister Pack Carton SAMPLE)

Principal Display Panel (75 mg Tablet Blister Pack Carton SAMPLE)
Packaging label for NURTEC ODT 75 mg orally disintegrating tablets, containing rimegepant sulfate, by Pfizer Laboratories Div Pfizer Inc. The label includes dosage form, strength, and patient sampling information. It notes this is a professional sample not for sale, with storage and usage instructions and contact information for more details on the product.*
FDA Label Image

Principal Display Panel (75 mg Tablet Blister Pack Dosepak SAMPLE)

Principal Display Panel (75 mg Tablet Blister Pack Dosepak SAMPLE)
NURTEC ODT 75 mg orally disintegrating tablets (rimegepant sulfate) carton label. The label includes usage instructions to peel back foil from blister pack and place tablet under the tongue to dissolve. Manufactured and distributed by Pfizer Laboratories Division of Pfizer Inc. The packaging emphasizes dry hands when opening and not pushing tablet through the foil backing.*
FDA Label Image

Principal Display Panel (75 mg NURTEC ODT Blister Pack SAMPLE)

Principal Display Panel (75 mg NURTEC ODT Blister Pack SAMPLE)
NURTEC ODT 75 mg orally disintegrating tablet packaging label showing two tablets. The label states the active ingredient as rimegepant (orally disintegrating tablets), with a strength of 75 mg each. The label includes instructions 'Peel Here' and indicates 'Professional Sample - Not for Sale' along with the Pfizer Laboratories Div Pfizer Inc labeler information. Lot and expiration date fields are also present but not filled.*
FDA Label Image

Principal Display Panel (75 mg 2 Tablet Blister Pack Carton SAMPLE)

Principal Display Panel (75 mg 2 Tablet Blister Pack Carton SAMPLE)
Carton label for NURTEC ODT (rimegepant) 75 mg orally disintegrating tablets, a prescription drug by Pfizer Laboratories Div Pfizer Inc. The label includes the product name, strength, dosage form, storage instructions, removal directions for the tablet, and a QR code for patient copay information. It also shows lot, expiration placeholders, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.